黄芪甲苷治疗心力衰竭研究OA
Research on Astragaloside Ⅳ in the Treatment of Heart Failure
心力衰竭(heart failure,HF)作为一种严重的全球性公共卫生问题,因其高发病率和病死率,给患者健康和社会经济带来了巨大负担.传统中药因其多靶点、多途径的治疗特性,在心力衰竭的防治中展现出独特优势.黄芪甲苷(astragaloside IV,AS-Ⅳ)作为黄芪的主要活性成分,近年来在慢性心力衰竭领域的研究中备受关注.大量实验和临床研究表明,黄芪甲苷通过多种机制发挥心脏保护作用,诸如改善心肌缺血状态、调节钙离子稳态、促进血管新生、优化心肌能量代谢,以及抑制心脏肥大和纤维化过程,减少心肌细胞凋亡.上述作用共同协同,有效减缓心力衰竭的进展.该文综述了黄芪甲苷治疗心力衰竭的最新机制研究进展,旨在为其临床应用和新药开发提供理论依据和研究方向.
Heart failure(HF)is a major global public-health problem that imposes a heavy clinical and socioeconomic burden because of its high morbidity and mortality.Traditional Chinese medicine,with their multi-target and multi-pathway characteristics,have shown unique advantages in HF prevention and treatment.Astragaloside Ⅳ,the principal active constituent of Huangqi(Astragali Radix),has attracted increasing attention in chronic-HF research.Numerous experimental and clinical studies have demonstrated that AS-Ⅳ exerts comprehensive cardioprotective effects by improving myocardial ischemia,modulating calcium homeostasis,promoting angiogenesis,optimizing myocardial energy metabolism,and inhibiting cardiac hypertrophy and fibrosis while reducing cardiomyocyte apoptosis.These synergistic actions effectively slow HF progression.This review summarizes the latest mechanistic findings on AS-Ⅳin HF,aiming to provide a theoretical basis and research direction for its clinical application and new-drug development.
郑剑;周鹏;王仕清;于天一;于泽宇;王佳音
黑龙江中医药大学附属第三医院,黑龙江 哈尔滨 150036黑龙江中医药大学,黑龙江 哈尔滨 150040黑龙江中医药大学附属第三医院,黑龙江 哈尔滨 150036黑龙江中医药大学附属第三医院,黑龙江 哈尔滨 150036黑龙江中医药大学附属第三医院,黑龙江 哈尔滨 150036哈尔滨职业技术学院,黑龙江 哈尔滨 150081
医药卫生
黄芪甲苷心力衰竭机制心肌保护传统中药
astragaloside Ⅳheart failuremechanismmyocardial protectiontraditional Chinese medicine
《辽宁中医药大学学报》 2026 (9)
51-56,6
黑龙江省中医药科研项目(ZYW2024-012)
评论